-
-
-
-
-
-
-
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
-
-
-
-
-
-
-
Sage Therapeutics (SAGE) PT Lowered to $215 at Ladenburg Thalmann
-
-
-
-
-
-
-
SAGE Therapeutics (SAGE) Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in Treatment of PPD
-
-
11,811 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All